267 related articles for article (PubMed ID: 24778450)
1. Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.
Tifrea DF; Pal S; Popot JL; Cocco MJ; de la Maza LM
J Immunol; 2014 Jun; 192(11):5201-13. PubMed ID: 24778450
[TBL] [Abstract][Full Text] [Related]
2. Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine.
Tifrea DF; Sun G; Pal S; Zardeneta G; Cocco MJ; Popot JL; de la Maza LM
Vaccine; 2011 Jun; 29(28):4623-31. PubMed ID: 21550371
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of amphipol-conjugated adjuvant with antigen, and adjuvant combinations, enhance immune protection elicited by a membrane protein-based vaccine against a mucosal challenge with Chlamydia.
Tifrea DF; Pal S; Le Bon C; Giusti F; Popot JL; Cocco MJ; Zoonens M; de la Maza LM
Vaccine; 2018 Oct; 36(45):6640-6649. PubMed ID: 30293763
[TBL] [Abstract][Full Text] [Related]
4. The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge.
Pal S; Tifrea DF; Follmann F; Andersen P; de la Maza LM
Vaccine; 2017 Mar; 35(13):1705-1711. PubMed ID: 28238632
[TBL] [Abstract][Full Text] [Related]
5. Improved protection against Chlamydia muridarum using the native major outer membrane protein trapped in Resiquimod-carrying amphipols and effects in protection with addition of a Th1 (CpG-1826) and a Th2 (Montanide ISA 720) adjuvant.
Tifrea DF; Pal S; le Bon C; Cocco MJ; Zoonens M; de la Maza LM
Vaccine; 2020 Jun; 38(28):4412-4422. PubMed ID: 32386746
[TBL] [Abstract][Full Text] [Related]
6. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.
Pal S; Tatarenkova OV; de la Maza LM
Immunology; 2015 Nov; 146(3):432-43. PubMed ID: 26423798
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with major outer membrane protein proteosomes elicits protection in mice against a Chlamydia respiratory challenge.
Tifrea DF; Pal S; Toussi DN; Massari P; de la Maza LM
Microbes Infect; 2013 Nov; 15(13):920-7. PubMed ID: 23999313
[TBL] [Abstract][Full Text] [Related]
8. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
[TBL] [Abstract][Full Text] [Related]
9. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.
Sun G; Pal S; Weiland J; Peterson EM; de la Maza LM
Vaccine; 2009 Aug; 27(36):5020-5. PubMed ID: 19446590
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.
Pal S; Favaroni A; Tifrea DF; Hanisch PT; Luczak SET; Hegemann JH; de la Maza LM
Vaccine; 2017 May; 35(19):2543-2549. PubMed ID: 28385608
[TBL] [Abstract][Full Text] [Related]
11. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
Hansen J; Jensen KT; Follmann F; Agger EM; Theisen M; Andersen P
J Infect Dis; 2008 Sep; 198(5):758-67. PubMed ID: 18652549
[TBL] [Abstract][Full Text] [Related]
12. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
[TBL] [Abstract][Full Text] [Related]
13. Induction of protection in mice against a respiratory challenge by a vaccine formulated with the Chlamydia major outer membrane protein adjuvanted with IC31®.
Cheng C; Cruz-Fisher MI; Tifrea D; Pal S; Wizel B; de la Maza LM
Vaccine; 2011 Mar; 29(13):2437-43. PubMed ID: 21276442
[TBL] [Abstract][Full Text] [Related]
14. A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge.
Cheng C; Pal S; Tifrea D; Jia Z; de la Maza LM
Microbes Infect; 2014 Mar; 16(3):244-52. PubMed ID: 24291713
[TBL] [Abstract][Full Text] [Related]
15. CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.
Farris CM; Morrison SG; Morrison RP
Infect Immun; 2010 Oct; 78(10):4374-83. PubMed ID: 20660610
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.
Yu H; Karunakaran KP; Jiang X; Brunham RC
Vaccine; 2014 Aug; 32(36):4672-80. PubMed ID: 24992718
[TBL] [Abstract][Full Text] [Related]
17. Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine.
Carmichael JR; Pal S; Tifrea D; de la Maza LM
Vaccine; 2011 Jul; 29(32):5276-83. PubMed ID: 21609745
[TBL] [Abstract][Full Text] [Related]
18. Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.
Karunakaran KP; Yu H; Jiang X; Chan Q; Moon KM; Foster LJ; Brunham RC
Vaccine; 2015 Apr; 33(18):2159-66. PubMed ID: 25738816
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
Tifrea DF; Ralli-Jain P; Pal S; de la Maza LM
Infect Immun; 2013 May; 81(5):1741-50. PubMed ID: 23478318
[TBL] [Abstract][Full Text] [Related]
20. The
Verma R; Sahu R; Dixit S; Duncan SA; Giambartolomei GH; Singh SR; Dennis VA
Front Immunol; 2018; 9():2369. PubMed ID: 30374357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
